Targeting regulatory T cells in cancer.

@article{Byrne2011TargetingRT,
  title={Targeting regulatory T cells in cancer.},
  author={William L. Byrne and Kingston H G Mills and James A. Lederer and Gerald C O'sullivan},
  journal={Cancer research},
  year={2011},
  volume={71 22},
  pages={6915-20}
}
Infiltration of tumors by regulatory T cells confers growth and metastatic advantages by inhibiting antitumor immunity and by production of receptor activator of NF-κB (RANK) ligand, which may directly stimulate metastatic propagation of RANK-expressing cancer cells. Modulation of regulatory T cells can enhance the efficacy of cancer immunotherapy. Strategies include depletion, interference with function, inhibition of tumoral migration, and exploitation of T-cell plasticity. Problems with… CONTINUE READING

From This Paper

Topics from this paper.
69 Citations
33 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 69 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Transient T cell depletion causes regression ofmelanomametastases

  • MA Rasku, AL Clem, S Telang, B Taft, K Gettings, H Gragg
  • J Transl Med
  • 2008
Highly Influential
4 Excerpts

Stimulation of the glucocorticoid-induced TNF receptor familyrelated receptoronCD8Tcells inducesprotectiveandhigh-avidityTcell responses to tumor-specific antigens

  • AL Côt e, P Zhang, JA O'Sullivan, VL Jacobs, CR Clemis, S Sakaguchi
  • J Immunol
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…